Next Generation Sequencing (NGS)
Next Generation Sequencing (NGS) is an intervention with 8 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
3
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Cell-free DNA in Hereditary And High-Risk Malignancies 1
Optimization of Sepsis Therapy Based on Patient-specific Digital Precision Diagnostics
Endometriosis and Peritoneal Dysbiosis
Mitochondrial Diseases - Long-read Genome and Transcriptome Sequencing in Cases Unresolved After Short-read Genomics
Clinical Trials (8)
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Cell-free DNA in Hereditary And High-Risk Malignancies 1
Optimization of Sepsis Therapy Based on Patient-specific Digital Precision Diagnostics
Endometriosis and Peritoneal Dysbiosis
Mitochondrial Diseases - Long-read Genome and Transcriptome Sequencing in Cases Unresolved After Short-read Genomics
Application of UCPCR as a Testing Tool for Identification of MODY Patients in the UAE
Genetic Causes of Gestational Diabetes in the Emirati Population
Genetic Causes of Hypercholesterolaemia in the Emirati Population
All 8 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 8